Daily as of 2 Nov 16:00 ET
- Price
- above both $220.83 vs 50 $184.00 / 200 $87.49
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 6 Jan 2026 · projected 26 bars out
MRNA | ModernaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$220.83
-$0.89 (-0.40%)
Moderna (MRNA) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.
The 50 SMA has sat above the 200 on the daily since Jan 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour. On the weekly a golden cross is projected within 10 bars.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $221.72 vs 50 $77.24 / 200 $81.81
- Projection
- 🟨Golden cross projected in 2 bars
- Test
- No active test
- Last cross
- 💀Death cross week of 21 Aug 2023 · projected 22 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $231.98 vs 50 $211.78 / 200 $126.37
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 22 Jun 2026 · projected 19 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 22 Jun 2026 | 🟨Golden | 4-hour | 19 bars out | Not tested |
| 1 Jun 2026 | 💀Death | 4-hour | 21 bars out | 3 bar cross test |
| 6 Jan 2026 | 🟨Golden moderate | daily | 26 bars out | Not tested |
| 17 Dec 2025 | 🟨Golden | 4-hour | 28 bars out | Not tested |
| 29 Aug 2025 | 💀Death | 4-hour | 30 bars out | — |
About MRNA
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$3B
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandlarge